Mario S. Brigiani
Bari, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical effect of proprotein convertase subtilisin/kexin type 9 inhibition in patients undergoing coronary artery bypass surgery.
Journal: JTCVS open
Published: October 16, 2025
Exploratory observational study with Two-year outcomes of early in-hospital evolocumab in acute coronary syndrome patients undergoing coronary artery bypass grafting.
Journal: Frontiers in cardiovascular medicine
Published: September 15, 2025
Hybrid Atrial Fibrillation Ablation: A Decade-Long Single-Center Experience.
Journal: Reviews in cardiovascular medicine
Published: June 12, 2025
Post-myocardial infarction ventricular septal defects: incidence and treatment trends during and after the COVID-19 pandemic.
Journal: Scientific reports
Published: August 16, 2024
Evolocumab Treatment in Dyslipidemic Patients Undergoing Coronary Artery Bypass Grafting: One-Year Safety and Efficacy Results.
Journal: Journal of clinical medicine
Published: April 17, 2024
Safety and Efficacy of PCSK9 Inhibitors in Patients with Acute Coronary Syndrome Who Underwent Coronary Artery Bypass Grafts: A Comparative Retrospective Analysis.
Journal: Journal of clinical medicine
Published: December 25, 2023
Emergent Conversion to Open Heart Surgery during Transcatheter Aortic Valve Implantation: The Presence of a Rescue Team Improves Outcomes.
Journal: Journal of clinical medicine
Published: October 29, 2023
Minimally Invasive Mitral Valve Repair for Standalone Secondary Mitral Regurgitation.
Journal: Heart, lung & circulation
Published: March 24, 2020
Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation.
Journal: The Journal of thoracic and cardiovascular surgery
Published: May 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026